Circulating irisin and glucose metabolism in overweight/obese women: effects of α-lipoic acid and eicosapentaenoic acid

Journal of Physiology and Biochemistry

Volumn 71, Issue 3, 2015, Pages 547-558

  Huerta, A E ^a   Prieto Hontoria, P L ^a,c   Fernandez Galilea M ^a,d   Sainz N ^a   Cuervo, M ^a,b   Martinez J A ^a,b   Moreno Aliaga, M J ^a,b  

^a UNIVERSITY OF NAVARRA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c Facultad de Estudios del Patrimonio Cultural   (Chile)

^d PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Eicosapentaenoic acid; Fndc5; Myokine adipokine; Obesity; Weight loss; Lipoic acid

Indexed keywords

GLUCOSE; ICOSAPENTAENOIC ACID; IRISIN; THIOCTIC ACID; FIBRONECTIN; FNDC5 PROTEIN, HUMAN; GLUCOSE BLOOD LEVEL;

ADIPOCYTE; ADULT; ANALYSIS OF VARIANCE; ARTICLE; BODY COMPOSITION; CELL DIFFERENTIATION; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; DUAL ENERGY X RAY ABSORPTIOMETRY; ENERGY EXPENDITURE; FEMALE; GLUCOSE METABOLISM; HIP CIRCUMFERENCE; HORMONE BLOOD LEVEL; HORMONE METABOLISM; HORMONE RELEASE; HORMONE SYNTHESIS; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO STUDY; LUNG GAS EXCHANGE; NORMAL HUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PHYSICAL ACTIVITY; RANDOMIZED CONTROLLED TRIAL; WAIST CIRCUMFERENCE; WAIST HIP RATIO; WEIGHT LOSS PROGRAM; BLOOD; CALORIC RESTRICTION; CELL CULTURE; DIET THERAPY; DRUG EFFECTS; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; PATHOLOGY; SUBCUTANEOUS FAT; TREATMENT OUTCOME; WEIGHT REDUCTION; WHITE ADIPOCYTE; YOUNG ADULT;

ADIPOCYTES, WHITE; ADULT; BLOOD GLUCOSE; CALORIC RESTRICTION; CELLS, CULTURED; DOUBLE-BLIND METHOD; EICOSAPENTAENOIC ACID; FEMALE; FIBRONECTINS; GLUCOSE; HUMANS; MIDDLE AGED; OBESITY; SUBCUTANEOUS FAT; THIOCTIC ACID; TREATMENT OUTCOME; WEIGHT LOSS; YOUNG ADULT;

EID: 84939468261     PISSN: 11387548     EISSN: 18778755     Source Type: Journal    
DOI: 10.1007/s13105-015-0400-5     Document Type: Article

References (41)

1. Benjamini Y, Hochberg Y (1995) Controlling the False discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B Methodol 57:289–300
2. Bostrom P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, Rasbach KA, Bostrom EA, Choi JH, Long JZ, Kajimura S, Zingaretti MC, Vind BF, Tu H, Cinti S, Hojlund K, Gygi SP, Spiegelman BM (2012) A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 481:463–468
3. Carbonelli MG, Renzo LD, Bigioni M, Daniele ND, Lorenzo AD, Fusco MA (2010) Alpha-lipoic acid supplementation: a tool for obesity therapy? Curr Pharm Des 16:840–846
4. Carlson DA, Smith AR, Fischer SJ, Young KL, Packer L (2007) The plasma pharmacokinetics of R-(+)-lipoic acid administered as sodium R-(+)-lipoate to healthy human subjects. Altern Med Rev J Clin Ther 12:343–351
5. Choi YK, Kim MK, Bae KH, Seo HA, Jeong JY, Lee WK, Kim JG, Lee IK, Park KG (2013) Serum irisin levels in new-onset type 2 diabetes. Diabetes Res Clin Pract 100:96–101
6. De la Iglesia R, Lopez-Legarrea P, Crujeiras AB, Pardo M, Casanueva FF, Zulet MA, Martinez JA (2013) Plasma irisin depletion under energy restriction is associated with improvements in lipid profile in metabolic syndrome patients. Clin Endocrinol (Oxf) 81:306–311
7. Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, Quagliaro L, Ceriello A, Giugliano D (2002) Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans role of oxidative stress. Circulation 106:2067–2072
8. Fernández-Galilea M, Perez-Matute P, Prieto-Hontoria P, Martinez JA, Moreno-Aliaga MJ (2011) Effects of lipoic acid on apelin in 3 T3-L1 adipocytes and in high-fat fed rats. J Physiol Biochem 67:479–486
9. Fernández-Galilea M, Pérez-Matute P, Prieto-Hontoria PL, Sáinz N, López-Yoldi M, Houssier M, Martínez JA, Langin D, Moreno-Aliaga MJ (2014) α-Lipoic acid reduces fatty acid esterification and lipogenesis in adipocytes from overweight/obese subjects. Obesity (Silver Spring) 22:2210–2215
10. Fernández-Galilea M, Prieto-Hontoria PL, Martínez JA, Moreno-Aliaga MJ (2013) Antiobesity effects of α-lipoic acid supplementation. Clin Lipidol 8:371–383
11. Gutierrez-Repiso C, Garcia-Serrano S, Rodriguez-Pacheco F, Garcia-Escobar E, Haro-Mora JJ, Garcia-Arnes J, Valdes S, Gonzalo M, Soriguer F, Moreno-Ruiz FJ, Rodriguez-Cañete A, Martinez-Ferriz A, Santoyo JS, Perez-Valero V, Garcia-Fuentes E (2014) FNDC5 could be regulated by leptin in adipose tissue. Eur J Clin Invest 44:918–925
12. Huerta AE, Navas-Carretero S, Prieto-Hontoria PL, Martínez JA, Moreno-Aliaga MJ (2014) Effects of alpha-lipoic acid and eicosapentaenoic acid in overweight and obese women during weigh loss. Obesity (Silver Spring) 23(2):313–321
13. Huh JY, Panagiotou G, Mougios V, Brinkoetter M, Vamvini MT, Schneider BE, Mantzoros CS (2012) FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism 61:1725–1738
14. Koh EH, Lee WJ, Lee SA, Kim EH, Cho EH, Jeong E, Kim DW, Kim MS, Park JY, Park KG, Lee HJ, Lee IK, Lim S, Jang HC, Lee KH, Lee KU (2011) Effects of alpha-lipoic Acid on body weight in obese subjects. Am J Med 124:85.e1–85.e8
15. Kurdiova T, Balaz M, Vician M, Maderova D, Vlcek M, Valkovic L, Srbecky M, Imrich R, Kyselovicova O, Belan V, Jelok I, Wolfrum C, Klimes I, Krssak M, Zemkova E, Gasperikova D, Ukropec J, Ukropcova B (2014) Effects of obesity, diabetes and exercise on Fndc5 gene expression and irisin release in human skeletal muscle and adipose tissue: in vivo and in vitro studies. J Physiol 592:1091–1107
16. Li D-J, Huang F, Lu W-J, Jiang G-J, Deng Y-P, Shen F-M (2014) Metformin promotes irisin release from murine skeletal muscle independently of AMP-activated protein kinase activation. Acta Physiol 213(3):711–721
17. Liu JJ, Wong MD, Toy WC, Tan CS, Liu S, Ng XW, Tavintharan S, Sum CF, Lim SC (2013) Lower circulating irisin is associated with type 2 diabetes mellitus. J Diabetes Complicat 27:365–369
18. Lopez-Legarrea P, de la Iglesia R, Crujeiras AB, Pardo M, Casanueva FF, Zulet MA, Martinez JA (2014) Higher baseline irisin concentrations are associated with greater reductions in glycemia and insulinemia after weight loss in obese subjects. Nutr Diabetes 4:e110
19. Lorente-Cebrián S, Costa AG, Navas-Carretero S, Zabala M, Martinez JA, Moreno-Aliaga MJ (2013) Role of omega-3 fatty acids in obesity, metabolic syndrome, and cardiovascular diseases: a review of the evidence. J Physiol Biochem 69:633–651
20. Manning PJ, Sutherland WHF, McGrath MM, De Jong SA, Walker RJ, Williams MJA (2008) Postprandial cytokine concentrations and meal composition in obese and lean women. Obesity (Silver Spring) 16:2046–2052
21. Moreno-Aliaga MJ, Lorente-Cebrián S, Martínez JA (2010) Regulation of adipokine secretion by n-3 fatty acids. Proc Nutr Soc 69:324–332
22. Moreno-Navarrete JM, Ortega F, Serrano M, Guerra E, Pardo G, Tinahones F, Ricart W, Fernandez-Real JM (2013) Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J Clin Endocrinol Metab 98:E769–E778
23. Murata M, Kaji H, Takahashi Y, Iida K, Mizuno I, Okimura Y, Abe H, Chihara K (2000) Stimulation by eicosapentaenoic acids of leptin mRNA expression and its secretion in mouse 3 T3-L1 adipocytes in vitro. Biochem Biophys Res Commun 270:343–348
24. Norheim F, Langleite TM, Hjorth M, Holen T, Kielland A, Stadheim HK, Gulseth HL, Birkeland KI, Jensen J, Drevon CA (2014) The effects of acute and chronic exercise on PGC-1α, irisin and browning of subcutaneous adipose tissue in humans. FEBS J 281:739–749
25. Pardo M, Crujeiras AB, Amil M, Aguera Z, Jiménez-Murcia S, Baños R, Botella C, de la Torre R, Estivill X, Fagundo AB, Fernández-Real JM, Fernández-García JC, Fruhbeck G, Gómez-Ambrosi J, Rodríguez R, Tinahones FJ, Fernández-Aranda F, Casanueva FF (2014) Association of irisin with fat mass, resting energy expenditure, and daily activity in conditions of extreme body mass index. Int J Endocrinol 2014:857270
26. Pérez-Echarri N, Pérez-Matute P, Marcos-Gómez B, Martínez JA, Moreno-Aliaga MJ (2009) Effects of eicosapentaenoic acid ethyl ester on visfatin and apelin in lean and overweight (cafeteria diet-fed) rats. Br J Nutr 101:1059–1067
27. Pérez-Matute P, Marti A, Martinez JA, Fernández-Otero MP, Stanhope KL, Havel PJ, Moreno-Aliaga MJ (2005) Eicosapentaenoic fatty acid increases leptin secretion from primary cultured rat adipocytes: role of glucose metabolism. Am J Physiol Integr Comp Physiol 288:R1682–R1688
28. Pérez-Matute P, Pérez-Echarri N, Martínez JA, Marti A, Moreno-Aliaga MJ (2007) Eicosapentaenoic acid actions on adiposity and insulin resistance in control and high-fat-fed rats: role of apoptosis, adiponectin and tumour necrosis factor-alpha. Br J Nutr 97:389–398
29. Prieto-Hontoria PL, Pérez-Matute P, Fernández-Galilea M, Barber A, Martínez JA, Moreno-Aliaga MJ (2009) Lipoic acid prevents body weight gain induced by a high fat diet in rats: effects on intestinal sugar transport. J Physiol Biochem 65:43–50
30. Prieto-Hontoria PL, Pérez-Matute P, Fernández-Galilea M, Martínez JA, Moreno-Aliaga MJ (2011) Lipoic acid inhibits leptin secretion and Sp1 activity in adipocytes. Mol Nutr Food Res 55:1059–1069
31. Prieto-Hontoria PL, Pérez-Matute P, Fernández-Galilea M, Martínez JA, Moreno-Aliaga MJ (2012) Effects of lipoic acid on AMPK and adiponectin in adipose tissue of low- and high-fat-fed rats. Eur J Nutr 52(2):779–787
32. Roca-Rivada A, Castelao C, Senin LL, Landrove MO, Baltar J, Crujeiras AB, Seoane LM, Casanueva FF, Pardo M (2013) FNDC5/irisin is not only a myokine but also an adipokine. PLoS One 8:e60563
33. Sánchez J, Nozhenko Y, Palou A, Rodríguez AM (2013) Free fatty acid effects on myokine production in combination with exercise mimetics. Mol Nutr Food Res 57:1456–1467
34. Sesti G, Andreozzi F, Fiorentino TV, Mannino GC, Sciacqua A, Marini MA, Perticone F (2014) High circulating irisin levels are associated with insulin resistance and vascular atherosclerosis in a cohort of nondiabetic adult subjects. Acta Diabetol 51:705–713
35. Shan T, Liang X, Bi P, Kuang S (2013) Myostatin knockout drives browning of white adipose tissue through activating the AMPK-PGC1α-Fndc5 pathway in muscle. FASEB J 27:1981–1989
36. Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F (2008) The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord 6:299–304
37. Stengel A, Hofmann T, Goebel-Stengel M, Elbelt U, Kobelt P, Klapp BF (2013) Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity–correlation with body mass index. Peptides 39:125–130
38. Wang Y, Li X, Guo Y, Chan L, Guan X (2010) alpha-Lipoic acid increases energy expenditure by enhancing adenosine monophosphate-activated protein kinase-peroxisome proliferator-activated receptor-gamma coactivator-1alpha signaling in the skeletal muscle of aged mice. Metabolism 59:967–976
39. Yan W, Li N, Hu X, Huang Y, Zhang W, Wang Q, Wang F, Wang C, Zhai X, Xu R, Yan K, Ding X, Wang X (2013) Effect of oral ALA supplementation on oxidative stress and insulin sensitivity among overweight/obese adults: a double-blinded, randomized, controlled, cross-over intervention trial. Int J Cardiol 167:602–603
40. Yan B, Shi X, Zhang H, Pan L, Ma Z, Liu S, Liu Y, Li X, Yang S, Li Z (2014) Association of serum irisin with metabolic syndrome in obese Chinese adults. PLoS One 9:e94235
41. Zhang HJ, Zhang XF, Ma ZM, Pan LL, Chen Z, Han HW, Han CK, Zhuang XJ, Lu Y, Li XJ, Yang SY, Li XY (2013) Irisin is inversely associated with intrahepatic triglyceride contents in obese adults. J Hepatol 59(3):557–562